Type III collagen metabolism in soft tissue sarcomas

9Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Sera of 85 patients with benign soft tissue lesions or sarcomas of soft tissues were investigated for a collagen metabolite, the aminoterminal propeptide of type III procollagen (PIIINP). Patients were divided into three groups: benign soft tissue lesions (n = 39), localised (n = 29) and metastatic (n = 18) soft tissue sarcomas (STS). Values of PIIINP above the reference range were found in 15%, 28% and 50% of the respective groups. The difference in the concentration of PIIINP was statistically significant between the benign lesions and the localised sarcomas; P = 0.05, and between the benign lesions and the metastatic sarcomas; P< 0.001. In localised sarcomas there was a correlation between PIIINP and bone-involvement (r = 0.61, P = 0.002) and in metastatic disease between PIIINP and liver metastases (r = 0.77, P< 0.001). In localised sarcomas the overall survival for patients with a value of PIIINP above the reference range was significantly poorer (P = 0.03) than for patients with values within the reference range, even after stratification for the histological malignancy grade of the tumours (P = 0.04). © Macmillan Press Ltd., 1992.

Cite

CITATION STYLE

APA

Wiklund, T. A., Elomaa, I., Blomqvist, C. P., Risteli, L., & Risteli, J. (1992). Type III collagen metabolism in soft tissue sarcomas. British Journal of Cancer, 65(2), 193–196. https://doi.org/10.1038/bjc.1992.40

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free